Drug Type Small molecule drug |
Synonyms Edicotinib (USAN), Edicotinib hydrochloride, JNJ-244 + [5] |
Target |
Mechanism CSF-1R antagonists(Colony stimulating factor 1 receptor antagonists) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H35N5O2 |
InChIKeyBNVPFDRNGHMRJS-UHFFFAOYSA-N |
CAS Registry1142363-52-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cognition Disorders | Phase 2 | GB | 01 Jul 2019 | |
Refractory acute myeloid leukemia | Phase 2 | US | 05 Oct 2018 | |
Relapsing acute myeloid leukemia | Phase 2 | US | 05 Oct 2018 | |
Crohn Disease | Phase 2 | AT | 20 Mar 2018 | |
Crohn Disease | Phase 2 | DE | 20 Mar 2018 | |
Crohn Disease | Phase 2 | HU | 20 Mar 2018 | |
Crohn Disease | Phase 2 | PL | 20 Mar 2018 | |
Crohn Disease | Phase 2 | RU | 20 Mar 2018 | |
Crohn Disease | Phase 2 | ES | 20 Mar 2018 | |
Crohn Disease | Phase 2 | UA | 20 Mar 2018 |
Phase 2 | 95 | fxonwlggcr(cabysaoxld) = hdeqpadthw vhhhtnmhfc (ifmwmyvkgs ) View more | Negative | 01 Oct 2015 | |||
Placebo | fxonwlggcr(cabysaoxld) = jpgrkcdrfn vhhhtnmhfc (ifmwmyvkgs ) View more | ||||||
Phase 1/2 | 21 | cjogvlovvn(vrqqrcwbzo) = dftzisizzd bhdtzdpfjj (kdtqvprvvr ) View more | Negative | 15 Apr 2015 |